| Literature DB >> 21283560 |
Kumaresh Ghosh1, Tanmay Sarkar, Asoke P Chattopadhyay.
Abstract
A new anthracene labeled pyridinium amide-urea conjugate 1 has been designed and synthesized. The receptor shows a different fluorometric response with L-N-acetylvaline and L-N-acetylalanine salts in CH₃CN in contrast to the other salts of L-N-acetyl α-amino acids and (S)-α-hydroxy acids studied. Upon complexation of the tetrabutylammonium salt of L-N-acetylvaline, the emission of 1 increases accompanied by the formation of a new band at higher wavelength and this characteristic change distinguishes it from other anionic substrates studied. The binding interaction has been studied by ¹H NMR, fluorescence and UV titration experiments.Entities:
Keywords: DFT calculation; N-acetyl-L-valine salt; emission decay; fluorometric detection; pyridinium amide–urea conjugate
Year: 2010 PMID: 21283560 PMCID: PMC3028924 DOI: 10.3762/bjoc.6.139
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Figure 1Synthesized compounds 1 and 2.
Scheme 1Syntheses of 1 and 2.
Figure 2Change in 1H NMR of (A) 1 (400 MHz, CDCl3 containing 0.4% d6-DMSO; c = 2.80 × 10−3 M) and in the presence of equivalent amount of (B) L-N-acetylvaline, (C) L-N-acetylproline salts.
Figure 3Change in fluorescence ratio of 1 upon addition of one equivalent of anions (c = 4.31 × 10−5 M) at 492 nm.
Figure 4Change in emission of 1 (c = 4.31 × 10−5 M) upon gradual addition of tetrabutylammonium salts of (a) L-N-acetylvaline and (b) L-N-acetylalanine.
Figure 5Suggested modes of binding of the amino acid salts into the open cleft of 1.
Figure 6Fluorescence titration curves for 1 (c = 4.31 × 10−5 M) at 492 nm.
Figure 7Fluorescence decays (at λmax = 420 nm) of receptor 1 upon the addition of 1 equiv of L-N-acetylvaline salt ([H] = 4.71 × 10−5 M, [G] = 9.42 × 10−4 M) in CH3CN.
Fluorescence decay times (τ), and preexponential factors for 1 and 2 in CH3CN.
| Receptor in presence and absence of guest | Fluorescence decay time τ (preexponential factor) |
| τ1 = 0.46 ps ( 100%), τ2 = 2.59 ns ( 0%) ; (χ2 = 1.43) | |
| τ1 = 1 ns (0.02%), τ2 = 4.23 ns (0.02%), τ3 = 0.62 ps (99.96%); (χ2 = 1.08) | |
| τ1 = 5.0 ps (58.83%), τ2 = 2.75 ns (41.17%); (χ2 = 1.03) | |
| τ1 = 2.5 ps (85.56%), τ2 = 2.76 ns (14.44%); (χ2 = 1.15) | |
| τ1 = 0.58 ps (99.98%), τ2 = 3.92 ns (0.02%); (χ2 = 1.54) | |
| τ1 = 0.63 ps (99.95%), τ2 = 3.87 ns (0.05%); (χ2 = 1.72) | |
| τ1 = 2.52 ps (65.38%), τ2 = 3.84 ns (34.62%); (χ2 = 1.69) | |
| τ1 = 0.49 ps (100%), τ2 = 4.18 ns (0%); (χ2 = 1.36) | |
Figure 8Change in absorbance of 1 (c = 4.31 × 10−5 M) upon gradual addition of tetrabutylammonium salts of L-N-acetylvaline.
Association constants (Ka) in CH3CN from fluorescence measurements.
| Guesta | Receptor | Receptor |
| L- | 1.87 x 104; R = 0.998c | 1.30 x 103; R = 0.988c |
| L- | 2.60 x 103; R = 0.995d | 6.50 x 102; R = 0.993c |
| L- | 1.38 x 103; R = 0.993c | —b |
| L- | 1.31 x 103; R = 0.989c | —b |
| acetate | 2.20 x 103; R = 0.997c | 1.70 x 103; R = 0.998c |
| ( | 1.60 x 103; R = 0.995c | —b |
| pyruvate | —b | —b |
atetrabutylammonium salts were used; bnot determined due to irregular change; cdetermined at 414 nm; ddetermined at 492 nm; eerror ≤ 10%.
Figure 9DFT optimized geometry of the complex of 1 with L-N-acetylvaline carboxylate salt [a = 1.93 Å, b = 1.99 Å, c = 1.64 Å, d = 1.97 Å, e = 2.60 Å and f = 2.69 Å].